BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29706651)

  • 1. Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
    Chang JW; Kuo WH; Lin CM; Chen WL; Chan SH; Chiu MF; Chang IS; Jiang SS; Tsai FY; Chen CH; Huang PH; Chang KJ; Lin KT; Lin SC; Wang MY; Uen YH; Tu CW; Hou MF; Tsai SF; Shen CY; Tung SL; Wang LH
    Oncogene; 2018 Jul; 37(30):4137-4150. PubMed ID: 29706651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer.
    Tseng RC; Chang JW; Mao JS; Tsai CD; Wu PC; Lin CJ; Lu YL; Liao SY; Cheng HC; Hsu HS; Wang YC
    Oncotarget; 2015 Dec; 6(42):44207-21. PubMed ID: 26506240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The WASF3-NCKAP1-CYFIP1 Complex Is Essential for Breast Cancer Metastasis.
    Teng Y; Qin H; Bahassan A; Bendzunas NG; Kennedy EJ; Cowell JK
    Cancer Res; 2016 Sep; 76(17):5133-42. PubMed ID: 27432794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
    Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
    Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.
    Shi M; Cao M; Song J; Liu Q; Li H; Meng F; Pan Z; Bai J; Zheng J
    Mol Cancer; 2015 Mar; 14():66. PubMed ID: 25888829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IQGAP1 and NWASP promote human cancer cell dissemination and metastasis by regulating β1-integrin via FAK and MRTF/SRF.
    Cerutti C; Lucotti S; Menendez ST; Reymond N; Garg R; Romero IA; Muschel R; Ridley AJ
    Cell Rep; 2024 Apr; 43(4):113989. PubMed ID: 38536816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
    Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
    Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis.
    Sun Q; Lesperance J; Wettersten H; Luterstein E; DeRose YS; Welm A; Cheresh DA; Desgrosellier JS
    J Clin Invest; 2018 Jan; 128(1):531-544. PubMed ID: 29227280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
    Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
    Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer.
    Gu X; Wang Y; Wang H; Ni Q; Zhang C; Zhu J; Huang W; Xu P; Mao G; Yang S
    Med Oncol; 2015 Jul; 32(7):195. PubMed ID: 26033031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAG1 promotes the inherent radioresistance of laryngeal cancer cells via activation of STAT3.
    Shen L; Ke Q; Chai J; Zhang C; Qiu L; Peng F; Deng X; Luo Z
    Exp Cell Res; 2018 Sep; 370(1):127-136. PubMed ID: 29913153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling.
    Liu Y; Wang Z; Huang D; Wu C; Li H; Zhang X; Meng B; Li Z; Zhu T; Yang S; Sun W
    Oncotarget; 2017 Feb; 8(6):9513-9524. PubMed ID: 27880729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
    Deng X; Zhao Y; Wu X; Song G
    Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disabled-1 is down-regulated in clinical breast cancer and regulates cell apoptosis through NF-κB/Bcl-2/caspase-9.
    Cao RJ; Li K; Xing WY; Du S; Li Q; Zhu XJ; Cui SS
    J Cell Mol Med; 2019 Feb; 23(2):1622-1627. PubMed ID: 30484953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer.
    Tai YL; Chu PY; Lai IR; Wang MY; Tseng HY; Guan JL; Liou JY; Shen TL
    Sci Rep; 2015 Nov; 5():16408. PubMed ID: 26549523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer.
    Li W; Liu Z; Zhao C; Zhai L
    Oncol Rep; 2015 Sep; 34(3):1345-52. PubMed ID: 26134759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer.
    Grawenda AM; Møller EK; Lam S; Repapi E; Teunisse AF; Alnæs GI; Børresen-Dale AL; Kristensen VN; Goding CR; Jochemsen AG; Edvardsen H; Bond GL
    Cancer Res; 2015 Feb; 75(4):698-708. PubMed ID: 25649770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.